NMPA Approval

Group ACYW135 Menningococcal Conjugate Vaccine (CRM197)

Approval Number

国药准字S20210054

Company康希诺生物股份公司

Registration Date

December 27, 2021

Drug Information

Generic Name

ACYW135群脑膜炎球菌多糖结合疫苗(CRM197载体)

Trade Name

曼海欣

Dosage Form

注射剂

Strength

按标示量复溶后每瓶0.5ml，每1次人用剂量0.5ml，含A群、C群结合多糖各10μg，含Y群、W135群结合多糖各5μg。

Drug Type

生物制品

Registration Date

December 27, 2021

Company Information

Applicant Company

Company Name康希诺生物股份公司

Company Address

天津经济技术开发区西区南大街185号西区生物医药园四层401-420

Manufacturing Company

Company Name康希诺生物股份公司

Company Address

天津市滨海新区开发西区新桂路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

ACYW135群脑膜炎球菌多糖结合疫苗(CRM197载体) - NMPA 批准文号 | MedPath